Discover Nexalin’s Neurostimulation Device Targeting Mental Health DisordersNEXALIN29 ביולי 2024זמן קריאה 0 דקותעודכן: 29 במאי
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging DataHOUSTON, TX, May 13, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in...
Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public OfferingHOUSTON, May 06, 2025 — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial...
Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common StockHOUSTON, May 05, 2025 — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial...
Comentários